Biomarin Pharmaceutical Inc

Cambridge Investment Research Advisors, Inc. BMRN
Report date
6/30/2026
Quarter
2026 Q2
Filed
7/27/2026
Shares
21,829
Value ($000)
1,249
Weight
0.0%
2025 Q4 - 2026 Q2 (3 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).